Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic AMPA subunit 4 (GluA4) is one of four subunits (GluA1–GluA4, encoded by GRIA1–GRIA4) that assemble as tetrameric ligand-gated ion channels, mediating rapid excitatory neurotransmission in the brain. AMPA receptors are key mediators of fast synaptic transmission at glutamatergic synapses and play essential roles in processes such as learning, memory, and plasticity. Most native receptors are heterotetramers, with different subunit combinations giving rise to distinct physiological and pharmacological properties. GluA4 participates in the formation of the cation-selective ion channel pore and determines the receptor’s gating, ion selectivity, and kinetics. Dysfunction or dysregulation of AMPA receptors, including GluA4, is implicated in several neurological and neurodegenerative diseases, making these receptors important therapeutic targets for conditions like epilepsy, ALS, and other CNS disorders. Drugs targeting AMPA receptors can act directly by blocking the ion channel or allosterically modulating the receptor, with effects on neuronal activity, excitotoxicity, and synaptic plasticity.
Competitive antagonism at the glutamate binding site (e.g., NBQX); Noncompetitive antagonism/allosteric inhibition of ion channel function (e.g., perampanel); Blockade of ion channel pore; Modulation of receptor desensitization and synaptic plasticity
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic AMPA subunit 4 (GluA4).